Godavari Biorefineries Gets Japanese Patent for Cancer Drug

Godavari Biorefineries Ltd has announced that the Japanese Patent Office has granted them a patent for "5-HYDROXY-1,4-NAPHTHALENEDIONE FOR USE IN THE TREATMENT OF CANCER." This novel compound has demonstrated significant efficacy against various cancer types, including breast and prostate cancer, by exhibiting strong inhibitory effects on cancer and cancer stem cells. The patent grant is a significant development for the company's biopharmaceutical research and development efforts.